MRL Ventures Fund
Corporate VC
MRL Ventures Fund (MRLV), Merck's corporate venture arm, invests globally in early-stage preclinical therapeutics companies to transform patient care.
Seed
Early Stage
Biotech
Healthcare
- Headquarters
- Cambridge, United States
- Founded
- 2015
- Website
- mrlv.com
- AUM
- $500.0M
- Last Investment
- May 2023
- Geographic Focus
- Global
Investment Thesis
Backs first-in-class therapeutics innovation across modalities, providing up to $25M capital, board roles, and Merck R&D expertise from concept to clinic.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account